Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/20 → 15/11/24 |
Funding
- Medical Research Future Fund MRFF
An open Label, Multicentre, Phase Study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS LYMPHOMA unsuitable for standard therapies
- Gandhi, Maher (Investigator 01)
- Cheah, Chan (Investigator 02)
- Dolcetti, Riccardo (Investigator 03)
- Polizzotto, Mark (Investigator 04)
- Keane, Colm (Investigator 05)
- Mollee, Peter (Investigator 06)
- Slavin, Monica (Investigator 07)
- Teh, Benjamin (Investigator 08)
- Krause, Lutz (Investigator 09)
- Scuffham, Paul (Investigator 10)